Tango Therapeutics Inc (TNGX) Shares Plummet Below 1-Year High

The stock price of Tango Therapeutics Inc (NASDAQ: TNGX) has plunged by -1.77 when compared to previous closing price of 7.91, but the company has seen a 2.37% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-08 that Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.32 per share a year ago.

Is It Worth Investing in Tango Therapeutics Inc (NASDAQ: TNGX) Right Now?

The 36-month beta value for TNGX is also noteworthy at 0.84. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for TNGX is 54.88M, and at present, short sellers hold a 19.37% of that float. The average trading volume of TNGX on May 10, 2024 was 619.46K shares.

TNGX’s Market Performance

The stock of Tango Therapeutics Inc (TNGX) has seen a 2.37% increase in the past week, with a 4.02% rise in the past month, and a -36.10% fall in the past quarter. The volatility ratio for the week is 6.36%, and the volatility levels for the past 30 days are at 5.63% for TNGX. The simple moving average for the past 20 days is 2.87% for TNGX’s stock, with a -11.02% simple moving average for the past 200 days.

Analysts’ Opinion of TNGX

Piper Sandler, on the other hand, stated in their research note that they expect to see TNGX reach a price target of $18. The rating they have provided for TNGX stocks is “Overweight” according to the report published on February 12th, 2024.

B. Riley Securities gave a rating of “Buy” to TNGX, setting the target price at $16 in the report published on December 08th of the previous year.

TNGX Trading at -7.87% from the 50-Day Moving Average

After a stumble in the market that brought TNGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.37% of loss for the given period.

Volatility was left at 5.63%, however, over the last 30 days, the volatility rate increased by 6.36%, as shares surge +2.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.49% lower at present.

During the last 5 trading sessions, TNGX rose by +2.37%, which changed the moving average for the period of 200-days by +155.59% in comparison to the 20-day moving average, which settled at $7.56. In addition, Tango Therapeutics Inc saw -21.52% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TNGX starting from MVA Investors, LLC, who sale 60,000 shares at the price of $7.61 back on May 03 ’24. After this action, MVA Investors, LLC now owns 483,524 shares of Tango Therapeutics Inc, valued at $456,600 using the latest closing price.

MVA Investors, LLC, the of Tango Therapeutics Inc, sale 75,000 shares at $7.56 during a trade that took place back on May 02 ’24, which means that MVA Investors, LLC is holding 543,524 shares at $567,000 based on the most recent closing price.

Stock Fundamentals for TNGX

Current profitability levels for the company are sitting at:

  • -3.39 for the present operating margin
  • 0.93 for the gross margin

The net margin for Tango Therapeutics Inc stands at -3.0. The total capital return value is set at -0.35. Equity return is now at value -45.41, with -27.57 for asset returns.

Based on Tango Therapeutics Inc (TNGX), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -3.16. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -217.11.

Currently, EBITDA for the company is -111.76 million with net debt to EBITDA at 0.18. When we switch over and look at the enterprise to sales, we see a ratio of 21.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.23.

Conclusion

In summary, Tango Therapeutics Inc (TNGX) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts